Last summer, Cerbios-Pharma SA (from now on “Cerbios”) commissioned SafeBridge Europe, Ltd. (from now on “SafeBridge”) to carry out a surrogate containment performance assessment of three isolators located in P5 manufacturing unit at Cerbios site located in Lugano, Switzerland.
![Cerbios_News_2010-8_-_Cerbios_HPAI_Manufacturing_unit_confirmed_Class_4.pdf Cerbios_News_2010-8_-_Cerbios_HPAI_Manufacturing_unit_confirmed_Class_4.pdf](/files/archives/p_Cerbios_News_2010-8_-_Cerbios_HPAI_Manufacturing_unit_confirmed_Class_4.jpg)
Linkedin